← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2020Last known activity
Dec 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (14 distinct, 9 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (16)
- NCT07021729Sponsor investigatorPhase 4Dec 31, 2025
- NCT07021729Lead sponsorPhase 4Dec 31, 2025
- NCT07040839Sponsor investigatorPhase 4Jul 31, 2025
- NCT07040839Lead sponsorPhase 4Jul 31, 2025
- NCT07015827Lead sponsorN/AJun 30, 2025
- NCT07017491Sponsor investigatorN/AJun 30, 2025
- NCT07015827Sponsor investigatorN/AJun 30, 2025
- NCT07017491Lead sponsorN/AJun 30, 2025
- NCT05292066Reponsible party - principal investigatorEarly Phase 1Oct 31, 2022
- NCT05343429Reponsible party - principal investigatorPhase 4Apr 1, 2022
- NCT05343429Lead sponsorPhase 4Apr 1, 2022
- NCT05249881CollaboratorEarly Phase 1Mar 10, 2022
- NCT05342376Lead sponsorPhase 4Feb 1, 2022
- NCT05342376Reponsible party - principal investigatorPhase 4Feb 1, 2022
- NCT05348980Lead sponsorPhase 4Jan 1, 2020
Details
- Last known activity
- Dec 31, 2025